001     290623
005     20250819141944.0
024 7 _ |a 10.1016/j.devcel.2024.05.013
|2 doi
024 7 _ |a pmid:38834071
|2 pmid
024 7 _ |a 1534-5807
|2 ISSN
024 7 _ |a 1878-1551
|2 ISSN
024 7 _ |a altmetric:164152971
|2 altmetric
037 _ _ |a DKFZ-2024-01209
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Shiraishi, Ryo
|b 0
245 _ _ |a Cancer-specific epigenome identifies oncogenic hijacking by nuclear factor I family proteins for medulloblastoma progression.
260 _ _ |a New York, NY
|c 2024
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1726063525_15964
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2024 Sep 9;59(17):2302-2319.e12
520 _ _ |a Normal cells coordinate proliferation and differentiation by precise tuning of gene expression based on the dynamic shifts of the epigenome throughout the developmental timeline. Although non-mutational epigenetic reprogramming is an emerging hallmark of cancer, the epigenomic shifts that occur during the transition from normal to malignant cells remain elusive. Here, we capture the epigenomic changes that occur during tumorigenesis in a prototypic embryonal brain tumor, medulloblastoma. By comparing the epigenomes of the different stages of transforming cells in mice, we identify nuclear factor I family of transcription factors, known to be cell fate determinants in development, as oncogenic regulators in the epigenomes of precancerous and cancerous cells. Furthermore, genetic and pharmacological inhibition of NFIB validated a crucial role of this transcription factor by disrupting the cancer epigenome in medulloblastoma. Thus, this study exemplifies how epigenomic changes contribute to tumorigenesis via non-mutational mechanisms involving developmental transcription factors.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a brain tumor
|2 Other
650 _ 7 |a cerebellar granule cell
|2 Other
650 _ 7 |a cerebellum
|2 Other
650 _ 7 |a epigenome
|2 Other
650 _ 7 |a medulloblastoma
|2 Other
650 _ 7 |a mouse model
|2 Other
650 _ 7 |a nuclear factor I
|2 Other
700 1 _ |a Cancila, Gabriele
|b 1
700 1 _ |a Kumegawa, Kohei
|b 2
700 1 _ |a Torrejon, Jacob
|b 3
700 1 _ |a Basili, Irene
|b 4
700 1 _ |a Bernardi, Flavia
|b 5
700 1 _ |a Silva, Patricia Benites Goncalves da
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Wang, Wanchen
|b 7
700 1 _ |a Chapman, Owen
|b 8
700 1 _ |a Yang, Liying
|b 9
700 1 _ |a Jami, Maki
|b 10
700 1 _ |a Nishitani, Kayo
|b 11
700 1 _ |a Arai, Yukimi
|b 12
700 1 _ |a Xiao, Zhize
|b 13
700 1 _ |a Yu, Hua
|b 14
700 1 _ |a Lo Re, Valentina
|b 15
700 1 _ |a Marsaud, Véronique
|b 16
700 1 _ |a Talbot, Julie
|b 17
700 1 _ |a Lombard, Bérangère
|b 18
700 1 _ |a Loew, Damarys
|b 19
700 1 _ |a Jingu, Maho
|b 20
700 1 _ |a Okonechnikov, Konstantin
|0 P:(DE-He78)34b3639de467b2c700920d7cbc3d2110
|b 21
|u dkfz
700 1 _ |a Sone, Masaki
|b 22
700 1 _ |a Motohashi, Norio
|b 23
700 1 _ |a Aoki, Yoshitsugu
|b 24
700 1 _ |a Pfister, Stefan M
|0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
|b 25
|u dkfz
700 1 _ |a Chavez, Lukas
|b 26
700 1 _ |a Hoshino, Mikio
|b 27
700 1 _ |a Maruyama, Reo
|b 28
700 1 _ |a Ayrault, Olivier
|b 29
700 1 _ |a Kawauchi, Daisuke
|b 30
773 _ _ |a 10.1016/j.devcel.2024.05.013
|g p. S1534580724003307
|0 PERI:(DE-600)2053870-4
|n 17
|p 2302-2319.e12
|t Developmental cell
|v 59
|y 2024
|x 1534-5807
856 4 _ |u https://inrepo02.dkfz.de/record/290623/files/1-s2.0-S1534580724003307-main.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/290623/files/1-s2.0-S1534580724003307-main.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:inrepo02.dkfz.de:290623
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)34b3639de467b2c700920d7cbc3d2110
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 25
|6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-24
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-24
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b DEV CELL : 2022
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-24
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-24
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b DEV CELL : 2022
|d 2023-10-24
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21